NCT07193394
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07193394
Title Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer (H3RAKLES)
Acronym H3RAKLES
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Polyclinique Bordeaux Nord Aquitaine NOT_YET_RECRUITING Bordeaux 33 300 France Details
Chu Dupuytren- Limoges NOT_YET_RECRUITING Limoges 87 042 France Details
Institut Paoli-Calmettes NOT_YET_RECRUITING Marseille 13009 France Details
Centre Antoine Lacassagne NOT_YET_RECRUITING Nice 06 189 France Details
CHU de Nîmes NOT_YET_RECRUITING Nîmes 30 029 France Details
Centre Eugène Marquis NOT_YET_RECRUITING Rennes 35 042 France Details
Institut Curie_ Site Saint-Cloud RECRUITING Saint-Cloud 92 210 France Details
Institut Universitaire du Cancer de Toulouse (IUCT) - Oncopole Claudius Regaud NOT_YET_RECRUITING Toulouse 31 059 France Details
Institut de Cancérologie de Lorraine NOT_YET_RECRUITING Vandœuvre-lès-Nancy 54 519 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field